Publications View
BRD7 improves glucose homeostasis independent of IRS proteins.
Authors: Authors: Kim Y, Lee JM, Han Y, Tao R, White MF, Liu R, Park SW.
J Endocrinol
View full abstract on Pubmed
J Endocrinol
View full abstract on Pubmed
Hepatic follistatin increases basal metabolic rate and attenuates diet-induced obesity during hepatic insulin resistance.
Authors: Authors: Tao R, Stöhr O, Wang C, Qiu W, Copps KD, White MF.
Mol Metab
View full abstract on Pubmed
Mol Metab
View full abstract on Pubmed
Lower Hepatic Fat Is Associated With Improved Insulin Secretion in a High-Risk Prediabetes Subphenotype During Lifestyle Intervention.
Authors: Authors: Wagner R, Heni M, Kantartzis K, Sandforth A, Machann J, Schick F, Peter A, Fritsche L, Szendrödi J, Pfeiffer AFH, Schürmann A, Blüher M, Hauner H, Seissler J, Bornstein S, Roden M, Stefan N, Birkenfeld AL, White MF, Häring HU, Fritsche A.
Diabetes
View full abstract on Pubmed
Diabetes
View full abstract on Pubmed
The role of hepatokines in NAFLD.
Authors: Authors: Stefan N, Schick F, Birkenfeld AL, Häring HU, White MF.
Cell Metab
View full abstract on Pubmed
Cell Metab
View full abstract on Pubmed
Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex.
Authors: Authors: Xie L, Yuan Y, Xu S, Lu S, Gu J, Wang Y, Wang Y, Zhang X, Chen S, Li J, Lu J, Sun H, Hu R, Piao H, Wang W, Wang C, Wang J, Li N, White MF, Han L, Jia W, Miao J, Liu J.
Cell Rep
View full abstract on Pubmed
Cell Rep
View full abstract on Pubmed
The P300 acetyltransferase inhibitor C646 promotes membrane translocation of insulin receptor protein substrate and interaction with the insulin receptor.
Authors: Authors: Peng J, Ramatchandirin B, Wang Y, Pearah A, Namachivayam K, Wolf RM, Steele K, MohanKumar K, Yu L, Guo S, White MF, Maheshwari A, He L.
J Biol Chem
View full abstract on Pubmed
J Biol Chem
View full abstract on Pubmed
Elevated circulating follistatin associates with an increased risk of type 2 diabetes.
Authors: Authors: Wu C, Borné Y, Gao R, López Rodriguez M, Roell WC, Wilson JM, Regmi A, Luan C, Aly DM, Peter A, Machann J, Staiger H, Fritsche A, Birkenfeld AL, Tao R, Wagner R, Canouil M, Hong MG, Schwenk JM, Ahlqvist E, Kaikkonen MU, Nilsson P, Shore AC, Khan F, Natali A, Melander O, Orho-Melander M, Nilsson J, Häring HU, Renström E, Wollheim CB, Engström G, Weng J, Pearson ER, Franks PW, White MF, Duffin KL, Vaag AA, Laakso M, Stefan N, Groop L, De Marinis Y.
Nat Commun
View full abstract on Pubmed
Nat Commun
View full abstract on Pubmed
TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states.
Authors: Authors: Xu S, Liu Y, Hu R, Wang M, Stöhr O, Xiong Y, Chen L, Kang H, Zheng L, Cai S, He L, Wang C, Copps KD, White MF, Miao J.
Elife
View full abstract on Pubmed
Elife
View full abstract on Pubmed
Insulin action at a molecular level - 100 years of progress.
From population to neuron: exploring common mediators for metabolic problems and mental illnesses.
Authors: Authors: Takayanagi Y, Ishizuka K, Laursen TM, Yukitake H, Yang K, Cascella NG, Ueda S, Sumitomo A, Narita Z, Horiuchi Y, Niwa M, Taguchi A, White MF, Eaton WW, Mortensen PB, Sakurai T, Sawa A.
Mol Psychiatry
View full abstract on Pubmed
Mol Psychiatry
View full abstract on Pubmed